KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to 18.81%.

  • Medtronic's EBITDA Margin fell 1700.0% to 18.81% in Q4 2025 from the same period last year, while for Oct 2025 it was 17.88%, marking a year-over-year increase of 14800.0%. This contributed to the annual value of 17.76% for FY2025, which is 18600.0% up from last year.
  • Per Medtronic's latest filing, its EBITDA Margin stood at 18.81% for Q4 2025, which was down 1700.0% from 16.85% recorded in Q3 2025.
  • In the past 5 years, Medtronic's EBITDA Margin registered a high of 21.37% during Q1 2022, and its lowest value of 10.75% during Q3 2021.
  • Over the past 5 years, Medtronic's median EBITDA Margin value was 18.16% (recorded in 2023), while the average stood at 17.47%.
  • In the last 5 years, Medtronic's EBITDA Margin soared by 143300bps in 2021 and then crashed by -60500bps in 2024.
  • Medtronic's EBITDA Margin (Quarter) stood at 19.92% in 2021, then fell by -7bps to 18.51% in 2022, then decreased by -9bps to 16.78% in 2023, then increased by 13bps to 18.98% in 2024, then decreased by -1bps to 18.81% in 2025.
  • Its last three reported values are 18.81% in Q4 2025, 16.85% for Q3 2025, and 16.09% during Q2 2025.